All lobbying filings

ALLIANCE FOR REGENERATIVE MEDICINE

Lobbying for ALLIANCE FOR REGENERATIVE MEDICINE · Advocacy organization supporting advances in regenerative medicine.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $230,000.00 expenses · posted Jan 20, 2026

Official filing document

Bills named in this filing 6

S 752
Accelerating Kids’ Access to Care Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 932
Give Kids a Chance Act of 2025
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 891
Bipartisan Health Care Act
S 1637
MVP Act

Lobbying activity 1

Health Issues

Advocate on issues related to regulation of, access to, and reimbursement for regenerative medicine companies and products. Value-based payment legislation and related CMS regulations. FDA appropriations and staffing. Biologics regulation. Prescription Drug User Fee Act (PDUFA). Medicaid. Medicare. Accelerating Kids Access to Care Act (S. 752 / H.R.1509). Mikaela Naylon Give Kids a Chance Act (S. 932 / H.R. 1262). Rare Pediatric Disease Priority Review Vouchers. Bipartisan Health Care Act (S. 891). MVP Act (S.1637). NIH appropriations. HHS oversight. HHS staffing and OPM issues. Medical research. Pharmaceutical tariffs. Biotechnology manufacturing. Newborn screening. FDA oversight.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.